跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,011 条关于
“DecisionDx-Melanoma”
全部
7,011
临床试验
5,689
药物
120
机构
8
资讯
1,194
去年
DecisionDx-Melanoma Test Reduces Unnecessary Biopsies in Melanoma Patients
9个月前
Castle Biosciences' Gene Expression Tests Show Superior Survival Prediction in Melanoma Patients
去年
GEP Tests Show Promise and Limitations in Melanoma Sentinel Lymph Node Biopsy Decisions
去年
31-Gene Expression Profile Test Safely Identifies Melanoma Patients Who Can Avoid Sentinel Lymph Node Biopsy
去年
Castle Biosciences' TissueCypher Test Receives New York State Approval for Barrett's Esophagus
去年
Real-World Study Validates DecisionDx-UM Test with PRAME Biomarker for Improved Uveal Melanoma Risk Stratification
3个月前
Wait Times Beyond 68 Days for Sentinel Node Biopsy Linked to Worse Melanoma Survival in the Adjuvant Therapy Era
上个月
Study Finds Strong Link Between Cutaneous Melanoma and Uveal Melanoma Risk
去年
FDA Grants Priority Review to Replimune's RP1 Plus Nivolumab for Advanced Melanoma
去年
Nevisense AI Tool Significantly Improves Melanoma Biopsy Decisions in US and German Study
第 1 页,共 120 页
上一页
下一页